Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.78 CHF | -0.06% | +2.20% | -2.11% |
27/04 | Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022. | CI |
26/04 | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
Sales 2024 * | 190M 210M 17.51B | Sales 2025 * | 101M 111M 9.27B | Capitalization | 2.29B 2.53B 211B |
---|---|---|---|---|---|
Net income 2024 * | 152M 168M 14.01B | Net income 2025 * | 72M 79.6M 6.63B | EV / Sales 2024 * | 13.6 x |
Net Debt 2024 * | 291M 322M 26.81B | Net Debt 2025 * | 324M 359M 29.9B | EV / Sales 2025 * | 26 x |
P/E ratio 2024 * |
15.1
x | P/E ratio 2025 * |
14
x | Employees | 10 |
Yield 2024 * |
5.62% | Yield 2025 * |
5.74% | Free-Float | 97.24% |
1 day | -0.06% | ||
1 week | +2.20% | ||
Current month | +1.21% | ||
1 month | -1.99% | ||
3 months | -14.68% | ||
6 months | +8.84% | ||
Current year | -2.11% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Koller
CIO | Chief Investment Officer | 54 | 01/04/01 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Meanwell
BRD | Director/Board Member | 67 | 01/04/01 |
Director/Board Member | 63 | 01/20/01 | |
Chairman | 63 | 21/19/21 |
Date | Price | Change | Volume |
---|---|---|---|
16/24/16 | 41.85 | +0.12% | 39 140 |
15/24/15 | 41.8 | +0.72% | 56,218 |
14/24/14 | 41.5 | +0.97% | 88,537 |
13/24/13 | 41.1 | +0.37% | 130,396 |
10/24/10 | 40.95 | -3.87% | 119,714 |
Delayed Quote Swiss Exchange, May 16, 2024 at 07:49 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.11% | 2.54B | |
+31.16% | 49.46B | |
+1.13% | 42.58B | |
+49.05% | 42.49B | |
-5.26% | 29.09B | |
+12.66% | 26.61B | |
-23.80% | 18.64B | |
+7.25% | 13.16B | |
+31.42% | 12.55B | |
+23.06% | 12.1B |
- Stock Market
- Equities
- BION Stock